Global Computer-Aided Detection Market Size, Trends, and Analysis - Forecasts to 2026 By Application (Breast Cancer, Lung Cancer, Colon/Rectal Cancer, Prostate Cancer, Liver Cancer, Bone Cancer, and Neurological/Musculoskeletal Cancer), By Breast CAD Imaging Modalities (Mammography, Magnetic Resonance Imaging, Ultrasound Imaging, Tomosynthesis, and Nuclear Imaging), By Imaging Modalities (X-Ray Imaging, Computed Tomography, Ultrasound Imaging, Magnetic Resonance, and Nuclear Medicine Imaging), By Region (North America, Europe, Asia Pacific, MEA, and CSA); End-User Landscape, Company Market Share Analysis & Competitor Analysis
Computer-Aided Detection is a newly introduced mechanism or technology that assists radiologists in avoiding the risk of overlooking the medical images and misinterpreting those images during diagnostics. This particular technology is very beneficial in detecting if any lesion is malignant. Today, many medical organizations have been focusing on reducing the risks of observational oversights, thus decreasing the false-negative rate.
In recent years, the usage of radiology has significantly been utilized in various medical verticals like hospitals and other clinical centers to detect the presence of any disorders or diseases. This radiological process involves visual perception and interpretation. However, many surveys have proved that the abnormalities in the radiographic images are not accurately reported and are missed from the human sight. Strategies and technologies like computer-aided detection were developed to address such issues and fallacies in medical centers. Today, with a rising percentage of cancer diagnosed in individuals, the demand and usage for computer-aided detection are witnessing an upward trend within the healthcare sector of various countries across the world. Studies have shown that approximately 9.6 million people die every year due to delayed or inappropriate diagnosis of cancer and its stages. Also, out of the total deaths occurring due to cancer, 70% of them are reported in middle-income to low-income countries. This increasing awareness about increasing death rates due to the lack of a mechanism to detect such severe diseases as cancer makes countries adopt Computer-Aided Detection systems, which assist in yielding increased cancer detection rate.
Today, due to the incorporation of technology and automation in almost all sectors, Computer-Aided Detection in the medical sector is also highly adapted. The conventional and traditional way of detecting diseases has been replaced by these automated computer-aided detection technologies to ensure more precision and avoid observational oversights, which tend to occur more to human sight as compared to technologically operated mechanisms. The application of computer-aided detection associated with its software provides a greater level of efficiencies in the working processes, thus accelerating the demand and growth for it within the global market.
Also, the increased awareness among the individuals to regularly undertake their routine health checkups has increased the utilization and need of computer-aided detection technologies or systems in medical centers. Public and private medical institutions have been investing tremendously in their computer-aided detection technologies to make sure their deliverance of services is efficient and there are no errors or inaccuracies in detecting diseases or disorders. These factors are boosting the growth in the computer-aided detection market.
The market is segregated across a range of applications: breast cancer, lung cancer, colon/rectal cancer, prostate cancer, liver cancer, bone cancer, and neurological/musculoskeletal cancer. Amongst these, the market leader will be breast cancer. Every year females diagnosed with breast cancer are comparatively higher than females diagnosed with any other type of cancer. According to the 2021 databases, United States reported approximately 281,550 invasive breast cancer cases and 49,290 cases of non-invasive breast cancer. These increased breast cancer cases have been propelling medical centers to utilize and apply computer-aided detection, thus accelerating growth significantly.
These increasing cases among women have encouraged many governmental and non-governmental institutes to undertake promotional and awareness programs to spread awareness among women to undertake regular breast cancer diagnostics, thus boosting the demand for computer-aided detection technologies or systems. In cooperation with various pharmaceutical divisions, the American Cancer Society had introduced Breast Cancer Awareness Month, also known as National Breast Cancer Awareness Month (NBCAM), which is being recognized all across the world and is celebrated in the whole month of October. Such campaigns have been successful in increasing awareness among females, thus accelerating growth in the computer-aided detection market.
The market is fragmented into mammography, magnetic resonance imaging, ultrasound imaging, tomosynthesis, and nuclear imaging modalities depending on breast CAD imaging. Among all, mammography predominates, accounting for the largest proportion of the market. Mammography is the most commonly used imaging modality across every medical division of various countries for conducting breast screen tests or computer-aided detections. Studies have shown that undertaking mammography every two years till the age of 20 is very crucial for every female across nations. This awareness has been accelerating the demand and growth for imaging modalities like mammography. Mammography is also being highly utilized as it reduces the chances of death due to breast cancer. Besides this, this imaging modality with its screening enables the doctors to detect cancer at its early stage, thus being able to cure it with non-invasive treatment procedures and avoid advanced chemotherapies. Also, mammograms enable women to keep a regular check on their breast health, thus being able to avoid breast cancer.
The CAD market is classified into five categories focused on imaging modalities: X-ray imaging, computed tomography, ultrasound imaging, magnetic resonance imaging, and nuclear medicine imaging. The X-Ray mode of imaging or screen diseases or disorders is highly utilized within various medical verticals, thus owning the largest share in the computer-aided detection market. Well-specialized and trained radiologists have been preferring X-rays as imaging modalities for many decades over any other modalities for screening in the computer-aided detection market. The accuracy and precision of details are facilitated more efficiently through X-rays than others. This particular imaging modality has also advanced in its techniques and output production by sophisticated technology, thus being utilized the most in the market.
Based on regional segmentation, North America has its dominance and holds its most significant share in the Computer-Aided Detection market. Countries like the United States annually report the highest number of females diagnosed with breast cancer. Also, these countries have tremendously contributed to spreading awareness about breast cancer across the nation through its American Cancer Society. These countries are thus, the most prominent adopters to and utilizers of computer-aided detection systems.
However, today, with significant contribution and awareness programs conducted by international organizations like the World Health Organization (WHO), the region of Asia Pacific is expected to witness fast growth in the computer-aided detection market during the forecasted period of 2021-2026. The contribution of these international organizations has significantly helped middle-income or lower-income countries to adapt to these advancing technologies of computer-aided detection. Without proper mechanisms and technologies like these, the countries in the APAC region were initially very vulnerable to observational oversights, thus leading to increased death rates due to diseases and disorders. However, gradually, these rates are reducing due to the adoption of CAD. The emerging medical institutes and specialized radiologists are also propelling growth within the market. Intensified awareness and increased investment in medical equipment and diagnostic technologies are accelerating growth in the CAD market of the APAC region.
Toshiba Medical Systems Corporation, Philips Healthcare, EDDA Technology, Inc., Hitachi High Technologies Corporation, Hologic Inc., Vucomp, McKesson Corporation, Siemens Healthcare, iCAD, Inc, and Fujifilm Medical Systems are few prominent competitors in the market.
Please note: This is not an exhaustive list of companies profiled in the report.
Chapter 1 Methodology
1.1 Market Scope & Definitions
1.2 Estimates & Forecast Calculation
1.3 Historical Data Overview And Validation
1.4 Data Sources
1.4.1 Secondary
1.4.2 Primary
Chapter 2 Report Outlook
2.1 Computer-Aided Detection Market Overview, 2019-2026
2.1.1 Industry Overview
2.1.2 Application Overview
2.1.3 Breast CAD Imaging Modalities Overview
2.1.4 Imaging Modalities Overview
2.1.5 Regional Overview
Chapter 3 Computer-Aided Detection Market Trends
3.1 Market Segmentation
3.2 Industry Background, 2019-2026
3.3 Market Key Trends
3.3.1 Positive Trends
3.3.1.1 Increasing cancer treatment awareness and routine medical check-up
3.3.1.2 Increasing demand of insurance policies
3.3.2 Industry Challenges
3.3.2.1 Bulk purchase by various group purchasing organizations
3.4 Prospective Growth Scenario
3.4.1 Application Growth Scenario
3.4.2 Breast CAD Imaging Modalities Growth Scenario
3.4.3 Imaging Modalities Growth Scenario
3.5 COVID-19 Influence over Industry Growth
3.6 Porter’s Analysis
3.7 PESTEL Analysis
3.8 Value Chain & Supply Chain Analysis
3.9 Regulatory Framework
3.9.1 North America
3.9.2 Europe
3.9.3 APAC
3.9.4 LATAM
3.9.5 MEA
3.10 Technology Overview
3.11 Market Share Analysis, 2020
3.11.1 Company Positioning Overview, 2020
Chapter 4 Computer-Aided Detection Market, By Application
4.1 Application Outlook
4.2 Breast Cancer
4.2.1 Market Size, By Region, 2019-2026 (USD Million)
4.3 Lung Cancer
4.3.1 Market Size, By Region, 2019-2026 (USD Million)
4.4 Colon/Rectal Cancer
4.4.1 Market Size, By Region, 2019-2026 (USD Million)
4.5 Prostate Cancer
4.5.1 Market Size, By Region, 2019-2026 (USD Million)
4.6 Liver Cancer
4.6.1 Market Size, By Region, 2019-2026 (USD Million)
4.7 Bone Cancer
4.4.1 Market Size, By Region, 2019-2026 (USD Million)
4.8 Neurological/Musculoskeletal Cancer
4.4.1 Market Size, By Region, 2019-2026 (USD Million)
Chapter 5 Computer-Aided Detection Market, By Breast CAD Imaging Modalities
5.1 Breast CAD Imaging Modalities Outlook
5.2 Mammography
5.2.1 Market Size, By Region, 2019-2026 (USD Million)
5.3 Magnetic Resonance Imaging
5.3.1 Market Size, By Region, 2019-2026 (USD Million)
5.4 Ultrasound Imaging
5.4.1 Market Size, By Region, 2019-2026 (USD Million)
5.5 Tomosynthesis
5.5.1 Market Size, By Region, 2019-2026 (USD Million)
5.6 Nuclear Imaging
5.6.1 Market Size, By Region, 2019-2026 (USD Million)
Chapter 6 Computer-Aided Detection Market, By Imaging Modalities
6.1 Imaging Modalities Outlook
6.2 X-Ray Imaging
6.2.1 Market Size, By Region, 2019-2026 (USD Million)
6.3 Computed Tomography
6.3.1 Market Size, By Region, 2019-2026 (USD Million)
6.4 Ultrasound Imaging
6.4.1 Market Size, By Region, 2019-2026 (USD Million)
6.5 Magnetic Resonance
6.5.1 Market Size, By Region, 2019-2026 (USD Million)
6.6 Nuclear Medicine Imaging
6.6.1 Market Size, By Region, 2019-2026 (USD Million)
Chapter 7 Computer-Aided Detection Market, By Region
7.1 Regional outlook
7.2 North America
7.2.1 Market Size, By Country 2019-2026 (USD Million)
7.2.2 Market Size, By Application, 2019-2026 (USD Million)
7.2.3 Market Size, By Breast CAD Imaging Modalities, 2019-2026 (USD Million)
7.2.4 Market Size, By Imaging Modalities, 2019-2026 (USD Million)
7.2.5 U.S.
7.2.5.1 Market Size, By Application, 2019-2026 (USD Million)
7.2.5.2 Market Size, By Breast CAD Imaging Modalities, 2019-2026 (USD Million)
7.2.5.3 Market Size, By Imaging Modalities, 2019-2026 (USD Million)
7.2.6 Canada
7.2.6.1 Market Size, By Application, 2019-2026 (USD Million)
7.2.6.2 Market Size, By Breast CAD Imaging Modalities, 2019-2026 (USD Million)
7.2.6.3 Market Size, By Imaging Modalities, 2019-2026 (USD Million)
7.3 Europe
7.3.1 Market Size, By Country 2019-2026 (USD Million)
7.3.2 Market Size, By Application, 2019-2026 (USD Million)
7.3.3 Market Size, By Breast CAD Imaging Modalities, 2019-2026 (USD Million)
7.3.4 Market Size, By Imaging Modalities, 2019-2026 (USD Million)
7.3.5 Germany
7.3.5.1 Market Size, By Application, 2019-2026 (USD Million)
7.3.5.2 Market Size, By Breast CAD Imaging Modalities, 2019-2026 (USD Million)
7.3.5.3 Market Size, By Imaging Modalities, 2019-2026 (USD Million)
7.3.6 UK
7.3.6.1 Market Size, By Application, 2019-2026 (USD Million)
7.3.6.2 Market Size, By Breast CAD Imaging Modalities, 2019-2026 (USD Million)
7.3.6.3 Market Size, By Imaging Modalities, 2019-2026 (USD Million)
7.3.7 France
7.3.7.1 Market Size, By Application, 2019-2026 (USD Million)
7.3.7.2 Market Size, By Breast CAD Imaging Modalities, 2019-2026 (USD Million)
7.3.7.3 Market Size, By Imaging Modalities, 2019-2026 (USD Million)
7.3.8 Italy
7.3.8.1 Market Size, By Application, 2019-2026 (USD Million)
7.3.8.2 Market Size, By Breast CAD Imaging Modalities, 2019-2026 (USD Million)
7.3.8.3 Market Size, By Imaging Modalities, 2019-2026 (USD Million)
7.3.9 Spain
7.3.9.1 Market Size, By Application, 2019-2026 (USD Million)
7.3.9.2 Market Size, By Breast CAD Imaging Modalities, 2019-2026 (USD Million)
7.3.9.2 Market Size, By Imaging Modalities, 2019-2026 (USD Million)
7.3.10 Russia
7.3.10.1 Market Size, By Application, 2019-2026 (USD Million)
7.3.10.2 Market Size, By Breast CAD Imaging Modalities, 2019-2026 (USD Million)
7.3.10.3 Market Size, By Imaging Modalities, 2019-2026 (USD Million)
7.4 Asia Pacific
7.4.1 Market Size, By Country 2019-2026 (USD Million)
7.4.2 Market Size, By Application, 2019-2026 (USD Million)
7.4.3 Market Size, By Breast CAD Imaging Modalities, 2019-2026 (USD Million)
7.4.4 Market Size, By Imaging Modalities, 2019-2026 (USD Million)
7.4.5 China
7.4.5.1 Market Size, By Application, 2019-2026 (USD Million)
7.4.5.2 Market Size, By Breast CAD Imaging Modalities, 2019-2026 (USD Million)
7.4.5.3 Market Size, By Imaging Modalities, 2019-2026 (USD Million)
7.4.6 India
7.4.6.1 Market Size, By Application, 2019-2026 (USD Million)
7.4.6.2 Market Size, By Breast CAD Imaging Modalities, 2019-2026 (USD Million)
7.4.6.3 Market Size, By Imaging Modalities, 2019-2026 (USD Million)
7.4.7 Japan
7.4.7.1 Market Size, By Application, 2019-2026 (USD Million)
7.4.7.2 Market Size, By Breast CAD Imaging Modalities, 2019-2026 (USD Million)
7.4.7.3 Market Size, By Imaging Modalities, 2019-2026 (USD Million)
7.4.8 Australia
7.4.8.1 Market Size, By Application, 2019-2026 (USD Million)
7.4.8.2 Market size, By Breast CAD Imaging Modalities, 2019-2026 (USD Million)
7.4.8.3 Market size, By Imaging Modalities, 2019-2026 (USD Million)
7.4.9 South Korea
7.4.9.1 Market Size, By Application, 2019-2026 (USD Million)
7.4.9.2 Market Size, By Breast CAD Imaging Modalities, 2019-2026 (USD Million)
7.4.9.3 Market Size, By Imaging Modalities, 2019-2026 (USD Million)
7.5 Latin America
7.5.1 Market Size, By Country 2019-2026 (USD Million)
7.5.2 Market Size, By Application, 2019-2026 (USD Million)
7.5.3 Market Size, By Breast CAD Imaging Modalities, 2019-2026 (USD Million)
7.5.4 Market Size, By Imaging Modalities, 2019-2026 (USD Million)
7.5.4 Brazil
7.5.5.1 Market Size, By Application, 2019-2026 (USD Million)
7.5.5.2 Market Size, By Breast CAD Imaging Modalities, 2019-2026 (USD Million)
7.5.5.3 Market Size, By Imaging Modalities, 2019-2026 (USD Million)
7.5.6 Mexico
7.5.6.1 Market Size, By Application, 2019-2026 (USD Million)
7.5.6.2 Market Size, By Breast CAD Imaging Modalities, 2019-2026 (USD Million)
7.5.6.3 Market Size, By Imaging Modalities, 2019-2026 (USD Million)
7.5.7 Argentina
7.5.7.1 Market Size, By Application, 2019-2026 (USD Million)
7.5.7.2 Market Size, By Breast CAD Imaging Modalities, 2019-2026 (USD Million)
7.5.7.3 Market Size, By Imaging Modalities, 2019-2026 (USD Million)
7.6 MEA
7.6.1 Market Size, By Country 2019-2026 (USD Million)
7.6.2 Market Size, By Application, 2019-2026 (USD Million)
7.6.3 Market Size, By Breast CAD Imaging Modalities, 2019-2026 (USD Million)
7.6.4 Market Size, By Imaging Modalities, 2019-2026 (USD Million)
7.6.5 Saudi Arabia
7.6.5.1 Market Size, By Application, 2019-2026 (USD Million)
7.6.5.2 Market Size, By Breast CAD Imaging Modalities, 2019-2026 (USD Million)
7.6.5.3 Market Size, By Imaging Modalities, 2019-2026 (USD Million)
7.6.6 UAE
7.6.6.1 Market Size, By Application, 2019-2026 (USD Million)
7.6.6.2 Market Size, By Breast CAD Imaging Modalities, 2019-2026 (USD Million)
7.6.6.3 Market Size, By Imaging Modalities, 2019-2026 (USD Million)
7.6.7 South Africa
7.6.7.1 Market Size, By Application, 2019-2026 (USD Million)
7.6.7.2 Market Size, By Breast CAD Imaging Modalities, 2019-2026 (USD Million)
7.6.7.3 Market Size, By Imaging Modalities, 2019-2026 (USD Million)
Chapter 8 Company Landscape
8.1 Competitive Analysis, 2020
8.2 Toshiba Medical Systems Corporation
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Strategic Positioning
8.2.4 Info Graphic Analysis
8.3 Philips Healthcare
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Strategic Positioning
8.3.4 Info Graphic Analysis
8.4 EDDA Technology, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Strategic Positioning
8.4.4 Info Graphic Analysis
8.5 Hitachi High Technologies Corporation
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Strategic Positioning
8.5.4 Info Graphic Analysis
8.6 Hologic Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Strategic Positioning
8.6.4 Info Graphic Analysis
8.7 Vucomp
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Strategic Positioning
8.7.4 Info Graphic Analysis
8.8 McKesson Corporation
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Strategic Positioning
8.8.4 Info Graphic Analysis
8.9 Siemens Healthcare
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Strategic Positioning
8.9.4 Info Graphic Analysis
8.10 iCAD, Inc
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Strategic Positioning
8.10.4 Info Graphic Analysis
8.11 Fujifilm Medical Systems
8.11.1 Company Overview
8.11.2 Financial Analysis
8.11.3 Strategic Positioning
8.11.4 Info Graphic Analysis
The Global Computer-Aided Detection Market has been studied from the year 2019 till 2026. However, the CAGR provided in the report is from the year 2021 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Computer-Aided Detection Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS